CLDI   $0.2483  2.73% Market Closed After Close 0.249 0.28%

Calidi Biotherapeutics, Inc.
Total Cash 836.00K
totalCashPerShare 0.103
EBITDA -29.18M
Total Debt 8.73M
quickRatio 0.078
currentRatio 0.125
Total Revenue
debtToEquity
Revenue/Share
ROA -2.22494
ROE
grossProfits
freeCashflow -47.57M
operatingCashflow -28.03M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 18.81M
forwardPE -1.5000001
floatShares 5.35M
sharesOutstanding 11.68M
sharesShort 110.83K
sharesShortPriorMonth 282.14K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.18%
heldPercentInstitutions 0.02%
Short Ratio help_outline 1.88%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -1.817
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -24.92M
trailingEps -3.85%
forwardEps -0.90%
enterpriseToEbitda -0.65
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.85 3Q 2024
institutionsCount 35
lastUpdated Nov. 2, 2024, 6:39 a.m.